Improving the regulatory review of drugs and devices: Improving access to generic drugs

Improving the regulatory review of drugs and devices: Improving access to generic drugs The updated regulations will help drug makers understand what information should be included in their drug submissions. This will help with product approval and availability. 2020-09-17 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyImproving access to generic drugsregulatory review of drugs and devices. Improving the regulatory review of drugs and devices: Improving access to generic drugsHTML https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/improving-access-generic-drugs.html Improving the regulatory review of drugs and devices: Improving access to generic drugsHTML https://www.canada.ca/fr/sante-canada/organisation/transparence/transparence-ouverture-en-matiere-reglementation/examens-reglementaire-materiel-medical/amelioration-acces-aux-medicaments-generiques.html

The updated regulations will help drug makers understand what information should be included in their drug submissions. This will help with product approval and availability.

Data and Resources

Similar records